Rod Wong, founder and CIO of RTW Investments, and Stephanie Sirota, its Chief Business Officer, dive deep into the unique landscape of healthcare investing. They tackle the complexities of drug investment phases and the crucial role of regulations. The guests compare founder-led biotech startups to larger firms, highlighting the societal impacts of innovations. They also discuss the evolution of investment strategies in biotech and the challenges posed by an ever-shifting pharmaceutical landscape, including pricing and M&A dynamics.